Braftovi (encorafenib) is a targeted cancer medicine used to treat cancers that have a specific genetic mutation called BRAF V600. It is a BRAF inhibitor, meaning it blocks a faulty protein produced by this mutated gene that drives cancer cell growth.
Braftovi is used to treat:
Before starting Braftovi, your doctor will test your tumour to confirm it has a BRAF V600 mutation.
Braftovi is only effective if this mutation is present.
How it works:
The BRAF gene normally helps control cell growth. When it mutates (particularly at V600), it becomes permanently switched on and drives uncontrolled cancer cell division. Braftovi blocks this faulty BRAF protein, slowing or stopping cancer growth. It is typically used alongside binimetinib or cetuximab for a more complete effect on the cancer signalling pathway.
Back To Top
Your dose:
For melanoma: the usual dose is 450mg (six 75mg capsules) once daily, taken alongside binimetinib.
For colorectal cancer: the usual dose is 300mg (four 75mg capsules) once daily.
Your doctor will confirm the right dose for your situation.
How to take it:
Before you start:
Ongoing check-ups:
You will need regular skin checks (for new skin cancers), eye assessments, heart monitoring (ECG), and blood tests during treatment. These are important, so attend all scheduled appointments.
Back To Top
Contact your doctor or pharmacist if you are unsure what to do.
Back To Top
If you think you have taken more than prescribed, call 000 or go to your nearest emergency department straight away.
Bring your medicine with you.
Signs that something might be wrong include:
Side effects are common.
Knowing what to watch for helps you manage them early.
Contact your doctor or pharmacist if any side effect concerns you.
Back To Top
Tell your doctor and pharmacist everything you are taking before starting Braftovi.
Key interactions include:
Never start, stop, or change any medicine without speaking to your doctor first.
Back To Top
What does BRAF V600 mutation mean?
BRAF is a gene that normally helps regulate cell growth. When it mutates at the V600 position, it becomes permanently switched on, causing cells to multiply uncontrollably. This mutation is found in about 40-50% of melanomas and in a smaller proportion of colorectal cancers. Medicines like Braftovi are specifically designed to target and block this mutation.
Why do I need to take Braftovi with another medicine?
Braftovi is used in combination with either binimetinib (for melanoma) or cetuximab (for colorectal cancer) because combining medicines that target different parts of the cancer signalling pathway is more effective at controlling cancer growth than either medicine alone. It also helps reduce the risk of resistance developing.
How long will I need to take Braftovi?
Treatment continues as long as your cancer is responding and you are tolerating the medicine. Your doctor will monitor your response through regular scans and assessments.
Back To Top
Ace provides accurate and independent information medically reviewed on prescription medications. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Back To Top